Novel anti-EPHA2 antibody, DS-8895a for cancer treatment

Overexpression of EPHA2 has been observed in multiple cancers and reported to be associated with poor prognosis. Here, we produced an afucosylated humanized anti-EPHA2 monoclonal antibody (mAb), DS-8895a for cancer treatment. The antibody recognizes the extracellular juxtamembrane region of EPHA2 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Jun, Sue, Mayumi, Yamato, Michiko, Ichikawa, Junya, Ishida, Saori, Shibutani, Tomoko, Kitamura, Michiko, Wada, Teiji, Agatsuma, Toshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137487/
https://www.ncbi.nlm.nih.gov/pubmed/27653549
http://dx.doi.org/10.1080/15384047.2016.1235663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137487/
https://www.ncbi.nlm.nih.gov/pubmed/27653549
http://dx.doi.org/10.1080/15384047.2016.1235663

Ejemplares similares